XZO vs YB Stock Comparison

Exzeo and Yuanbao Prices as of Oct 26, 2026 Peers: Industry group
XZO Exzeo Group, Inc.
$16.45 +8.1% 1M
Market cap
$1.46B
P/E
16.8x
Revenue (TTM)
$221.80M
Div. yield
–
Insurtech Technology
1 win
YB Yuanbao Inc.
$11.31 -7.4% 1M -51.9% 1Y
Market cap
$401.68M
P/E
1.0x
Revenue (TTM)
$721.91M
Div. yield
–
Insurtech Technology
6 wins

Head to Head

7 decided of 12

Yuanbao leads on 6 of the 12 questions below (Yuanbao 6, Exzeo 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionXZOYBLeader
Larger companyMarket capitalisation $1.46B $401.68M XZO
Cheaper on earningsLower P/E, profitable companies only 16.8x 1.0x YB
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.1x 2.7x YB
Faster revenue growthRevenue growth, trailing twelve months +21.8% +37.2% YB
More profitableNet margin, trailing twelve months 39.1% 57.3% YB
Better return on capitalReturn on invested capital — — –
Less leveragedLower net debt / EBITDA — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months — -51.9% –
Better 5-year returnAnnualised price return, 5 years — — –
Less volatileAnnualised volatility, 1 year 62.0% 51.3% YB
Higher overall scoreMean of the five percentile scores vs peers 82/100 89/100 YB

Percentile Scorecard

XZOYB

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisXZOYB
Valuation 65 #35 of 99 86 #15 of 99
Growth 81 #19 of 94 94 #7 of 94
Profitability 96 #5 of 90 99 #2 of 90
Financial Health 89 #13 of 105 87 #15 of 105
Shareholder Returns – 80 #13 of 61
Overall 82 89
  • XZO ranked among 109 companies in Fintech
  • YB ranked among 109 companies in Fintech

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodXZOYBSPY
1 month +8.1%-7.4% -0.8%
3 months +3.7%-20.2% +3.5%
6 months +0.7%-30.8% +7.0%
Year to date -32.2%-44.2% +12.2%
1 year —-51.9% +13.0%

Risk

MeasureXZOYBSPY
Volatility, 1Y 62.0%51.3% 12.7%
Downside volatility, 1Y 65.7%51.2% 12.7%
Beta vs S&P 500, 1Y 1.490.38 1.00
Return / volatility, 1Y —-1.01 1.02
Max drawdown, 5Y -48.2%-64.1% -25.4%
From 52-week high -32.2%-52.9% -1.8%
52-week high $24.25$24.00 $779.14
52-week low $12.55$11.08 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleXZOYB
P/E now vs peer median 16.7xmedian 20.6x 1.0xmedian 20.6x
P/S now vs peer median 6.7xmedian 2.3x 0.7xmedian 2.3x
EV/EBITDA now vs peer median 12.2xmedian 15.4x —median 15.4x
P/FCF now vs peer median 18.2xmedian 16.4x —median 16.4x
P/B now vs peer median 5.1xmedian 1.9x 0.9xmedian 1.9x
PEG now vs peer median —median 1.05 —median 1.05

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsXZOYB
Revenue $221.80M $721.91M
Gross profit $138.23M –
Operating income $107.60M –
Net income $86.81M $277.06M
Free cash flow $81.53M –
R&D $9.00M $59.06M
EPS (diluted) $0.98 $8.68
Cash & equivalents $136.73M $168.92M
Shares (diluted) 88.23M 47.65M
Enterprise value $647.53M -$1.97B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricXZOYB
P/E 16.7x 1.0x
P/FCF 18.2x –
P/Operating cash flow 17.7x –
P/S 6.7x 0.7x
P/B 5.1x 0.9x
P/Tangible book 5.1x 1.0x
EV/EBITDA 12.2x –
EV/EBIT 12.5x -0.9x
EV/Revenue 6.1x -0.3x
EV/FCF 16.5x –
EV/Operating cash flow 16.1x –
PEG (3Y EPS CAGR) – –

Growth

14 metrics
MetricXZOYB
Revenue growth (1Y) 21.8% 37.2%
Revenue CAGR (3Y) – –
Gross profit growth (1Y) 49.9% –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) 45.0% –
Operating income CAGR (3Y) – –
Net income growth (1Y) 53.5% 63.3%
Net income CAGR (3Y) – –
EPS growth (1Y) 37.0% 438.0%
EPS CAGR (3Y) – –
Operating cash flow growth (1Y) – –
Operating cash flow CAGR (3Y) – –
Free cash flow growth (1Y) – –
Free cash flow CAGR (3Y) – –

Profitability

14 metrics
MetricXZOYB
Gross margin 62.3% –
EBITDA margin 49.8% –
Operating margin 48.5% –
Pretax margin 52.4% 34.1%
Net margin 39.1% 57.3%
FCF margin 36.8% –
Operating cash flow margin 37.7% –
Return on equity 30.8% 50.4%
Return on assets 22.7% 33.2%
Return on invested capital – –
Return on capital employed 37.0% 45.5%
Asset turnover 0.6x 0.9x
Cash conversion (OCF / net income) 1.0x –
Stock comp / revenue 0.9% –

Financial Health

11 metrics
MetricXZOYB
Debt / assets – –
Debt / equity – –
Net debt / EBITDA – –
Debt / FCF – –
Liabilities / assets 25.3% 36.8%
Equity / assets 74.7% 63.2%
Interest coverage – –
Current ratio 1.8x 2.9x
Quick ratio 1.7x 2.8x
Cash ratio 1.5x 2.5x
Altman Z-score 11.11 3.55

Shareholder Returns

7 metrics
MetricXZOYB
Dividend yield – 11.1%
Net buyback yield – –
Shareholder yield – 11.1%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusXZOYB
Forward P/E 17.1xFY2026 2.7xFY2026
EPS, next fiscal year $0.96FY2026 $4.25FY2026
EPS growth, next FY -3.0%FY2026 +553.8%FY2026
EPS growth, the year after +24.0% +21.2%
Revenue, next fiscal year $232.90MFY2026 $881.23MFY2026
Revenue growth, next FY +13.2%FY2026 +41.0%FY2026
Revenue growth, the year after +4.5% +22.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersXZOYB
Held by institutions 7.1% 10.3%
Institutions holding 84 23
Change in shares held, QoQ -11.5% +20.8%
Institutions buying 58 14
Institutions selling 22 5
Buyers to sellers 2.64 2.80

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

XZOYB
XZO 1.00 0.06
YB 0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, XZO and YB?

Exzeo (XZO) is the largest by market capitalisation: Exzeo (XZO) $1.46B, Yuanbao (YB) $401.68M.

Which stock is cheaper, XZO and YB?

Yuanbao (YB) trades on the lowest price-to-earnings ratio (Exzeo (XZO) 16.8x, Yuanbao (YB) 1.0x). On next year's consensus earnings, Yuanbao (YB) is cheapest (Exzeo (XZO) 17.1x, Yuanbao (YB) 2.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Yuanbao (YB) grew revenue fastest over the trailing twelve months: Exzeo (XZO) +21.8%, Yuanbao (YB) +37.2%.

Which company is more profitable?

Yuanbao (YB) has the highest net margin (Exzeo (XZO) 39.1%, Yuanbao (YB) 57.3%).

Which stock is riskier?

By one-year price volatility, Yuanbao (YB) has been the steadiest (Exzeo (XZO) 62.0%, Yuanbao (YB) 51.3%). Volatility measures how widely the price swings, not the risk of the business.

Do XZO and YB move together?

Their daily returns over the past year have a correlation of 0.06, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, XZO and YB?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Yuanbao (YB) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.